{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:41:15Z","timestamp":1789846875019,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.breast.2018.08.103","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T12:50:38Z","timestamp":1535460638000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Chemosensitivity, tumor infiltrating lymphocytes (TILs), and survival of postpartum PABC patients treated by neoadjuvant chemotherapy"],"prefix":"10.1016","volume":"42","author":[{"given":"Julie","family":"Labrosse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e8s","family":"Abdennebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enora","family":"Laas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"Merckelbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marick","family":"Lae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Reyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Hamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2018.08.103_bib1","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/cncr.26643","article-title":"Pregnancy-associated breast cancer: an entity needing refinement of the definition","volume":"118","author":"Borges","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2018.08.103_bib2","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/annonc\/mdq642","article-title":"Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated breast cancer in the neoadjuvant setting","volume":"22","author":"Rouzier","year":"2011","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.breast.2018.08.103_bib3","first-page":"1145","article-title":"Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients","author":"Loibl","year":"2015","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.breast.2018.08.103_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.breast.2015.09.006","article-title":"Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: a case-control study of 87 cases","volume":"30","author":"Genin","year":"2016","journal-title":"Breast Edinb Scotl"},{"key":"10.1016\/j.breast.2018.08.103_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/mc.20058","article-title":"Mammary ECM composition and function are altered by reproductive state","volume":"41","author":"Schedin","year":"2004","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.breast.2018.08.103_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccr.2006.02.026","article-title":"Pregnancy and breast cancer: the other side of the coin","volume":"9","author":"Polyak","year":"2006","journal-title":"Canc Cell"},{"key":"10.1016\/j.breast.2018.08.103_bib7","article-title":"Tumor characteristics and prognosis in women with pregnancy-associated breast cancer","author":"Johansson","year":"2017","journal-title":"Int J Canc"},{"key":"10.1016\/j.breast.2018.08.103_bib8","first-page":"2447","article-title":"Pregnancy and post-partum breast cancer: a prospective study","volume":"28","author":"Mathelin","year":"2008","journal-title":"Anticanc Res"},{"key":"10.1016\/j.breast.2018.08.103_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/(SICI)1097-0215(19960917)67:6<751::AID-IJC1>3.0.CO;2-Q","article-title":"Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland breast cancer study group","volume":"67","author":"Lethaby","year":"1996","journal-title":"Int J Canc"},{"key":"10.1016\/j.breast.2018.08.103_bib10","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1200\/JCO.2012.45.6335","article-title":"Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study","volume":"31","author":"Amant","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2018.08.103_bib11","first-page":"183","article-title":"Postpartum breast cancers behaves differently","author":"Van den Rul","year":"2011","journal-title":"Facts Views Vis ObGyn"},{"key":"10.1016\/j.breast.2018.08.103_bib12","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/ijc.29181","article-title":"Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression","author":"Martinson","year":"2015","journal-title":"Int J Canc"},{"key":"10.1016\/j.breast.2018.08.103_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jnci\/djs505","article-title":"Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop","author":"Faupel-Badger","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2018.08.103_bib14","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1172\/JCI73777","article-title":"Cyclooxygenase-2\u2013dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer","volume":"124","author":"Lyons","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.breast.2018.08.103_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ctrv.2017.04.005","article-title":"Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: a meta-analysis of randomized controlled trials","volume":"57","author":"Solinas","year":"2017","journal-title":"Canc Treat Rev"},{"key":"10.1016\/j.breast.2018.08.103_bib16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.breast.2017.07.005","article-title":"Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: current state of the art","volume":"35","author":"Solinas","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.breast.2018.08.103_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.breast.2015.01.009","article-title":"Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy","volume":"24","author":"Azim","year":"2015","journal-title":"Breast Edinb Scotl"},{"key":"10.1016\/j.breast.2018.08.103_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1200\/JCO.2009.23.7370","article-title":"Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer","volume":"28","author":"Denkert","year":"2010","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2018.08.103_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1200\/JCO.2014.58.1967","article-title":"Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers","volume":"33","author":"Denkert","year":"2015","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2018.08.103_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.breast.2018.08.103_bib21","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2018.08.103_bib22","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J\u00a0Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2018.08.103_bib23","unstructured":"Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy: J Clin Oncol: Vol 25, No 28. Available at: http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2007.10.6823."},{"key":"10.1016\/j.breast.2018.08.103_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs working group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.breast.2018.08.103_bib25","series-title":"R: a language and environment for statistical computing","author":"R Development Core Team","year":"2011"},{"key":"10.1016\/j.breast.2018.08.103_bib26","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/cncr.22081","article-title":"Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero","volume":"107","author":"Hahn","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2018.08.103_bib27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bulcan.2017.03.012","article-title":"Clues to differentiate pregnancy-associated breast cancer from those diagnosed in postpartum period: a monocentric experience of pregnancy-associated cancer network (CALG)","volume":"104","author":"Boudy","year":"2017","journal-title":"Bull Canc (Paris)"},{"key":"10.1016\/j.breast.2018.08.103_bib28","first-page":"3414","article-title":"Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion","volume":"60","author":"Bemis","year":"2000","journal-title":"Canc Res"},{"key":"10.1016\/j.breast.2018.08.103_bib29","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2353\/ajpath.2006.050677","article-title":"Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis","volume":"168","author":"McDaniel","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.breast.2018.08.103_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrc1839","article-title":"Pregnancy-associated breast cancer and metastasis","volume":"6","author":"Schedin","year":"2006","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.breast.2018.08.103_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.breast.2017.07.008","article-title":"Epidemiology and pathophysiology of pregnancy-associated breast cancer: a review","volume":"35","author":"Ruiz","year":"2017","journal-title":"Breast Edinb Scotl"},{"key":"10.1016\/j.breast.2018.08.103_bib32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nm.2416","article-title":"Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2","volume":"17","author":"Lyons","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.breast.2018.08.103_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10549-016-3989-3","article-title":"The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis","volume":"160","author":"Hartman","year":"2016","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.breast.2018.08.103_bib34","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/1097-0142(19930415)71:8<2499::AID-CNCR2820710812>3.0.CO;2-S","article-title":"Estrogen receptor, progesterone receptor, and HER-2\/neu protein in breast cancers from pregnant patients","volume":"71","author":"Elledge","year":"1993","journal-title":"Cancer"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977618302571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977618302571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:39:10Z","timestamp":1760776750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977618302571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":34,"alternative-id":["S0960977618302571"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2018.08.103","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemosensitivity, tumor infiltrating lymphocytes (TILs), and survival of postpartum PABC patients treated by neoadjuvant chemotherapy","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2018.08.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}